All Type of News
A drugmaker caught bribing hospitals
The prosecution said on October 20 that Yuhan Corporation, the nation’s leading pharmaceutical firm, were found to have provided rebate-offerings of 50 billion won to area hospitals, according to a local news media.
...
Lawmaker backs issuance of compulsory license over essential drugs
A lawmaker said on October 20 that proper treatment has been unavailable due to shortage of orphan or essential drugs, such as Roche’s Fuzeon (enfuvirtide) and Shire’s Elaprase (idursulfase).
Rep. Chun Hyun-hee of ...
Hospitals urged to prescribe less medicines
Hospitals are prescribing many medications, putting heavier financial pressure on the state health insurance, according to the Health Insurance Review and Assessment Service (HIRA).
The agency said that more than 6...
Kwangdong to introduce new nucleoside analog RP101
Kwangdong Pharm says it has entered into an exclusive license with Germany based with respect to its lead drug candidate, RP101, for the treatment of pancreatic cancer.
The company will launch in RP101 in Korea in ...
LG CNS to team up with Inha University Hospital
LG CNS says it has signed a memorandum of understanding with Inha University Hosptal in Inchon to launch its home healthcare service through “Touch Dr.” for hypertensive and diabetic patients.
The Touch Dr.’s manag...
Cho named Abbott Korea pharmaceutical primary care chiefAbbott Korea has announced that Cho Ki-whan, executive managing director, was named as primary care leader of pharmaceutical business unit, effective October 20.
Cho will be ...
|
Pharmacy dispensing charge to rise 2.2% in 2009
Pharmacy dispensing charge to rise 2.2% in 2009
The National Health Insurance Corporation says it has agreed with the Korean Pharmaceutical Association to raise next year’s dispensing charges by 2.2 p...
Supreme Court upholds patent ruling against French drugmaker
The Supreme Court dismissed claims brought by French drugmaker Sanofi-Aventis SA in a patent lawsuit against Boryung Pharmaceutical Co. over its treatment for colorectal cancer, according to Boryung on October 15.
...
Korean drugs deemed expensive
A survey of 38 new drugs whose insurance prices were determined until September this year showed that Korean medicines are expensive by global standards.
The Health Insurance Review and Assessment Service reported ...
Pfizer’s new plan unlikely to affect Korean unit
Pfizer Inc’s drive to create more focused business units will not affect Pfizer Korea, its Korean business unit.
“Major restructuring in Pfizer Korea will be foreseeable in the near future as the pendulum of the ph...
